Company: SYRA
Filing Date: 2025-08-12
Form Type: 10-Q
Source: 0001641172-25-023235
Chunk: 80

Company: Syra Health Corp
Filing Date: 2025-08-12
Form: 10-Q
Item: Item 2
Chunk 80
---
 April 5, 2021, as amended.

On
June 16, 2025, the Board of Directors of the Company appointed Priya Prasad, the Company’s CFO and COO, as interim CEO.

On
July 1, 2025, the Company entered into a consulting agreement with a former member of the Board of Directors for services related to
developing a new strategic plan for the Company and identifying and hiring a new CEO.

On July 28,
2025, Deepika Vuppalanchi resigned from the Board of Directors of the Company for personal reasons.

Results
of Operations for the Three Months Ended June 30, 2025 and 2024

The
following table summarizes selected items from the statements of operations for the three months ended June 30, 2025 and 2024.

    For
    the Three Months  

    Ended  

    June
    30,  
    June
    30,  
    Increase
    / 

    2025  
    2024  
    (Decrease) 

    Net
    revenues 

    Healthcare
    workforce 
    $362,447  
    $1,416,234  
    $(1,053,787)
  
    Population
    health 
     1,583,752  
     533,025  
     1,050,727 
  
    Behavioral
    and mental health 
     -  
     20,422  
     (20,422)
  
    Net
    revenues 
     1,946,199  
     1,969,681  
     (23,482)
  
    Cost
    of services 
     1,193,304  
     1,619,674  
     (426,370)
  
    Gross
    profit 
     752,895  
     350,007  
     402,888 

    Operating
    expenses: 

    Salaries
    and benefits 
     326,354  
     847,064  
     (520,710)
  
    Professional
    fees 
     164,939  
     141,456  
     23,483 
  
    Research
    and development expenses 
     29,712  
     277,894  
     (248,182)